eszopiclone / Generic mfg.  >>  Phase 2
Welcome,         Profile    Billing    Logout  

5 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
eszopiclone / Generic mfg.
RESCUE-Combo, NCT04639193: Combination Drug-Therapy for Patients With Untreated Obstructive Sleep Apnea

Completed
2
20
US
Acetazolamide, Diamox, Eszopiclone, Lunesta, Placebo, Venlafaxine, Effexor
University of California, San Diego, American Thoracic Society
OSA, Obstructive Sleep Apnea
01/22
01/22
TOP-CPAP, NCT05951023: Endotype-Targeted Therapy to Rescue OSA Patients Struggling With CPAP Adherence

Recruiting
2
50
US
Eszopiclone 2 mg, Lunesta, Placebo
University of California, San Diego, American Academy of Sleep Medicine
Obstructive Sleep Apnea
11/24
12/24
ExPRESSION, NCT04875364: Do Endotypes Predict Response and Sequelae in OSA Patients

Recruiting
2
200
US
Eszopiclone, Lunesta, Supplemental Oxygen, Continuous Positive Airway Pressure (CPAP)
University of California, San Diego
Obstructive Sleep Apnea, Sleep Apnea, Sleep Apnea, Obstructive, Sleep, Sleep Disorder
01/27
01/27
NCT05953610: Endotypic Traits and Obstructive Sleep Apnea Surgery

Recruiting
2
150
US
Acetazolamide 500 MG QHS, Eszopiclone 3 mg QHS
University of California, Los Angeles, National Heart, Lung, and Blood Institute (NHLBI)
Obstructive Sleep Apnea
08/27
08/27
RescOSA, NCT05293600: Rescue Pharmacotherapy for OSA

Recruiting
1/2
70
US
Placebo, Acetazolamide, Trazodone, Atomoxetine and eszopiclone
Brigham and Women's Hospital
Obstructive Sleep Apnea
10/26
10/26

Download Options